Welcome to our dedicated page for Capital Bancorp SEC filings (Ticker: CBNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Capital Bancorp, Inc. filings document the regulatory disclosures of a Maryland bank holding company for Capital Bank, N.A. Recent Form 8-K reports cover quarterly and annual financial results, investor presentations, cash dividends, stock repurchase authorization, subordinated note redemption, and other material corporate events.
The company’s proxy and governance filings describe board structure, director elections and appointments, committee assignments, executive compensation, equity awards, and shareholder voting matters. Officer employment agreements and related compensatory arrangements appear in current reports, while capital-structure disclosures address common stock activity and bank holding company financing instruments.
Capital Bancorp Inc's Chief Risk Officer reported exercising stock options and changing their ownership in company shares.
On 12/15/2025, they acquired 6,680 shares of common stock at $13.89 per share and disposed of 3,137 shares at $29.58 per share, leaving 6,427 common shares beneficially owned directly. Following the exercise, 0 of the exercised options remain outstanding, but the officer continues to hold additional stock options for 4,000, 3,490, 4,105 and 2,004 shares at exercise prices of $26.41, $23.54, $24.2 and $30.51, along with 541 restricted stock units that will vest in four equal annual installments beginning 3/3/2026.
Capital Bancorp Inc director Jerome Ronnell Bailey reported exercising stock options for 4,250 shares of common stock on 12/15/2025 at an exercise price of $13.89 per share. The exercise converted previously held options into the same number of common shares.
After the transaction, he beneficially owned 56,093 Capital Bancorp common shares directly and 82,797 shares indirectly through The Jerome R Bailey Revocable Living Trust. He continues to hold additional stock options with various exercise prices and 1,081 restricted stock units that are scheduled to vest on 3/3/2026.
Capital Bancorp Inc. director Deborah Ratner Salzberg reported exercising 3,000 stock options for common stock on 12/12/2025 at an exercise price of $13.89 per share. To cover obligations, 1,410 shares were withheld and disposed of at $29.57 per share.
After these transactions, she directly owns 46,161 Capital Bancorp common shares and indirectly owns 14,632 shares through the Deborah Ratner Salzberg Trust. She also holds additional stock options covering 1,800, 2,352, 2,400 and 3,500 shares at exercise prices between $23.54 and $30.51, plus 946 restricted stock units scheduled to vest on 3/3/2026.
Capital Bancorp Inc director Joshua Bernstein reported exercising stock options for common stock on 12/09/2025. He acquired 936, 1,689, 1,394 and 850 shares through option exercises at exercise prices of $13.89, $26.41, $23.54 and $24.2, respectively.
After these transactions, he beneficially owns 89,828 shares of Capital Bancorp common stock directly. He also reports indirect ownership of 324,000 shares by Norman Bernstein, 154,400 shares by SandBern Ventures, LLC, and 303,200 shares by Bernstein Fund Limited Partnership.
Bernstein continues to hold derivative awards, including 4,000 stock options exercisable at $30.51 that expire on 03/03/2030, and 1,081 restricted stock units, each representing one share of common stock, scheduled to vest on 03/03/2026.
Capital Bancorp Inc (CBNK) director Mark M. Caplan reported his beneficial ownership of company securities as of an event dated 11/21/2025. He directly holds 138,690 shares of common stock. He also reports indirect ownership of 15,000 shares through Mark M. Caplan & Linda W. Caplan U/T, 45,000 shares through a Roth IRA, and 30,000 shares through an investment management account. In addition, he holds stock options covering 1,500, 1,800, 2,265, 2,800, and 3,000 shares at exercise prices between $13.89 and $30.51, plus 811 restricted stock units that are scheduled to vest on 3/3/2026.
Capital Bancorp, Inc. appointed Mark Caplan as a Class II director on its Board of Directors, effective November 21, 2025, increasing the Board size to thirteen members. As a Class II director, he will be up for re-election at the 2028 annual meeting of stockholders.
Mr. Caplan has served on the board of Capital Bank, N.A. since January 2019 and sits on its Loan Committee. He is President and Chief Executive Officer of The Time Group, a real estate equity investment firm, and the managing member and sole shareholder of Washington Place Equities, a development firm focused on mixed-use urban historic projects. He has prior bank board experience at Sterling Bank and Trust and Bay Bank, FSB.
The Board determined that Mr. Caplan is an independent director under SEC and Nasdaq rules. He was also appointed to the Board’s Compensation Committee and Risk Committee and will receive the Company’s standard non-employee director compensation. The Company states there are no related-party transactions or special arrangements connected to his selection as director.
Capital Bancorp Inc. (CBNK) director C. Scott Brannan reported multiple transactions in company stock on 11/21/2025. He exercised stock options for 3,000 shares of common stock at $13.89 per share, increasing his direct holdings to 5,505 shares immediately after the exercise. He then disposed of 2,282 shares in a transaction coded "F" at $26.66 per share, typically used for shares withheld or sold to cover taxes, leaving 3,223 directly held shares. Subsequent transactions coded "G" reflect gifts, including transfers of 965 shares from direct ownership and additions to Uniform Transfers to Minors Act (UTMA) accounts for four grandchildren, resulting in 2,258 directly held shares and several indirect positions. Brannan continues to hold multiple stock option grants and 946 restricted stock units that are scheduled to vest on 3/3/2026.
Capital Bancorp Inc. (CBNK) director Fred Joseph Lewis reported an insider transaction on 11/18/2025. He exercised stock options to acquire 3,750 shares of common stock at an exercise price of $13.89 per share (transaction code M). After this transaction, he beneficially owns 31,310 common shares directly and 16,672 shares indirectly through Dominion Insurance Inc.
Lewis continues to hold multiple stock option grants with exercise prices ranging from $23.54 to $30.51 and expiration dates between 12/31/2026 and 03/03/2030. He also holds 1,081 Restricted Stock Units, each representing one share of common stock, which are scheduled to vest on 03/03/2026.
Capital Bancorp Inc. (CBNK) director Steven J. Schwartz reported exercising stock options for 5,000 shares of common stock on 11/14/2025 at a price of $13.89 per share. Following this transaction, he beneficially owns 68,875 common shares directly and 663,313 shares indirectly through Prudent Investments, LLC. The filing also shows remaining stock options covering 2,750, 3,485, 4,400 and 4,000 shares at various exercise prices and expiration dates, as well as 1,081 restricted stock units, which are scheduled to vest on 3/3/2026 and convert into an equal number of common shares.
Capital Bancorp (CBNK) insider filing reports that the former EVP and CFO sold 3,400 shares of common stock at $27.95 on 11/12/2025.
Following the sale, the reporting person beneficially owned 1,434 shares directly. He also holds 500 stock options with a $21.57 exercise price, exercisable on 07/15/2025 and expiring on 07/15/2029. A footnote states that of an original 2,000 options, 1,500 were forfeited upon resignation on 10/27/2025, leaving 500 vested.